Patent Opposition Database

Hide annotations

Related patent application (please put in national patent application/publication number or PCT application/publication number): AR114353A1
Who filed: CILFA
Country: Argentina
Opposition type: Pre-Grant
Opposition status: Under Examination
Date: 28-07-2021
Patent type: Combination

Click within the document, or manually enter the page number below

CILFA opposition, rosuvastatin, (P000100408)

Countries: Argentina Date: 2002
CILFA opposition, benzoilguanidinas (Markush), (P990106043)

Countries: Argentina Date: 2003
CILFA opposition, dapagliflozin-empagliflozin-insulin, (AR112015A1)

Countries: Argentina Date: 2019
CILFA opposition, trelagliptin, (AR109064A2)

Countries: Argentina Date: 2019
CILFA opposition, LIXISENATIDE, (AR103415A1)

Countries: Argentina Date: 2017
CILFA opposition, Insulin LysB3 Glu B29, (AR096376A2)

Countries: Argentina Date: 2016
CILFA opposition, insulin analogues / derivatives, (AR095114A1)

Countries: Argentina Date: 2016
CILFA opposition, osimertinib, (AR115019A2)

Countries: Argentina Date: 2021
CILFA opposition, linaclotide, (AR118601A2)

Countries: Argentina Date: 2021
CILFA opposition, cannabidiol, (AR115578A1)

Countries: Argentina Date: 2021

Cilfa Opposition, Semaglutide, (Ar114353 A1)